Skip to main content

BioVenture — Portfolio, Page 11

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

274
Companies
$1.6B
Total invested
$24.7M
Avg. check
26
Industries
Health Care 18Biotechnology 16Medical 10Pharmaceutical 8Therapeutics 4Manufacturing 2+20 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 241264 of 274
Boan Biotech
October 2021

Boan Biotech is a biopharmaceutical company developing therapeutic antibodies.

Biotechnology · Yantai$18.8M Series B
NeuralGalaxy
August 2021

NeuralGalaxy is a brain science company which is devoted to solve brain disorders.

Health Care · Boston$77.3M Series A
Tvardi Therapeutics
June 2021

Tvardi Therapeutics is a Private, Clinical Stage Biotechnology Company.

Biotechnology · Houston$72.4M Series B
RecBio
June 2021

Focusing on major innovative vaccines with independent intellectual property rights.

Health Care · Taizhou$156.3M Series C
Innovative Molecules
June 2021

Innovative Molecules develops drugs designed to treat Herpes simplex-induced diseases.

Biotechnology · Munich$24.4M Series A
Bolt Biotherapeutics
June 2021

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Biotechnology · Redwood City$15.0M Post Ipo Equity
Stellanova Therapeutics
June 2021

Stellanova Therapeutics is a private, development-stage biotechnology company that focuses on cancer therapies

Biotechnology · Houston$15.5M Series A
GensKey
June 2021

GensKey is a genetic testing medical diagnostic service provider

Health Care · Beijing$15.7M Series C
Entasis Therapeutics
May 2021

Entasis Therapeutics is developing a portfolio of innovative cures.

Biotechnology · Waltham$7.5M Post Ipo Equity
Delta Medical
March 2021

Delta Medical is a Orthopedic instruments supplier.

Health Care · Beijing$20.1M Series E
Imcyse
February 2021

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

Biotechnology · Liège$25.7M Series B
Nirogy Therapeutics
January 2021

Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).

Biopharma · Natick$16.5M Series A
TCRyption
October 2020

TCRyption is a preclinical company focused on the development of novel approaches cellular therapy for cancer other indications.

Biotechnology · New York$10.0M Seed
Basecare
May 2020

Basecare is a manufacturing devices for embryonic pre-implantation genetic screening.

Genetics · Suzhou$21.1M Series C
X-ABT
March 2020

X-ABT is a diagnostic enterprise that provides detection solutions for pathogenic microbes.

Biotechnology · Changping$7.1M Series B
Bioheart
December 2019

Bioheart is develop high-value minimally invasive therapeutic products, provide better medical products and technologies.

Biotechnology · ShanghaiSeries B
Doctor Shaoyang
August 2019

Doctor Shaoyang is a Provider of a medical platform

Consulting · Guangzhou$7.1M Series A
ATFX
April 2019

A leading Forex CFD broker. Offers 300+ products globally. Recognized with 80+ awards for excellence in trading, service and CSR. On MT4/MT5

Financial Services · LondonSeries Unknown
HealthCare Biotech
March 2019

HealthCare Biotech is positioned to provide clinical diagnosis and guidance for clinical drug molecular diagnostic products.

Biotechnology · WuhanSeries B
NovaGo Therapeutics
March 2019

NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,

Biotechnology · Schlieren$10.0M Series A
AGS MedTech
December 2018

AGS MedTech is an invasive diagnosis and treatment equipment supplier.

Health Care · Hangzhou$420K Series A
Eden Biologics
October 2018

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Biopharma · HsinchuPost Ipo Equity
Refuge Biotechnologies
May 2018

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

Biotechnology · Menlo Park$25.0M Series B
Eucure Biopharma
March 2018

Eucure Biopharma is a biotechnology company that develops immuno-oncology targeted antibodies.

Biotechnology · Beijing$19.1M Series B

Where BioVenture invests

Health Care18
Biotechnology16
Medical10
Pharmaceutical8
Therapeutics4
Manufacturing2

About BioVenture's portfolio

How many companies has BioVenture invested in?

BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?

BioVenture's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 26 different industry categories.

What is BioVenture's largest investment?

Among tracked funding rounds, RecBio received $156.3M in a Series C round. BioVenture's total known invested capital is $1.6B.

What is the average investment size for BioVenture?

BioVenture's average investment size is $24.7M across its portfolio of 274 companies.

What are BioVenture's most recent investments?

Recent BioVenture portfolio additions include Boan Biotech, NeuralGalaxy, Tvardi Therapeutics, RecBio, Innovative Molecules. These companies were founded in 2020 or later.

Reach the founders behind these 274 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →